Meta Stock Price Is Down 30% From Its 52 Week High: Is META a Buy After the Child Safety Trial Drop

Meta stock has moved from a market favorite to a tougher debate in just a few months. The Meta stock price is now about 30% below its 52-week high of $790.80, and the latest child safety trial headline added another layer of pressure at current levels near the low $550s. That matters because the Meta stock price is no longer being judged only on ad growth. It is now being judged on legal risk, AI capital spending, and how quickly those investments turn into cash flow. This article looks at whether Meta stock is attractive here, or whether investors should wait for more proof.

At a Glance

• The 30% decline was not caused by one bad day. It built over months through heavy AI spending, margin pressure, legal overhang, and institutional selling.
• Today’s 4.4% drop looks more like an event-driven sentiment move tied to the start of the child safety trial than a fresh deterioration in Meta’s operating business.
• Meta’s core business is still strong, with Q2 2026 revenue of $60.801 billion and ad revenue of $59.4 billion, according to Meta investor materials.
• The buy case depends on three things: legal risk already being mostly priced in, Q3 revenue landing within the $61 billion to $64 billion guide, and signs that capital spending growth starts to slow.

What Produced the 30% Decline From the 52-Week High

The easiest mistake with Meta stock is to treat the recent drop as a single-event selloff. It was not. The decline from $790.80 to around $550 to $560 came from several layers of concern that stacked on top of each other and changed how investors value the business.

The first layer was AI infrastructure spending. Meta told investors that 2026 capital expenditures would land between $130 billion and $145 billion, while total expenses were guided to $165 billion to $169 billion, as reported by CNBC and reflected in company commentary. That kind of spending can make sense strategically, especially if AI improves ad targeting, recommendation systems, business agents, and compute services. But in the market, strategy only goes so far. Investors also want to see free cash flow hold up.

That leads to the second layer: margin and cash flow pressure. Meta’s Q2 2026 revenue was strong at $60.801 billion, up 28% year over year, and ad revenue came in at $59.4 billion, according to Meta Investor Relations. On the surface, that should support a strong stock. The problem is that free cash flow fell to $784 million in the quarter from $8.55 billion a year earlier, according to CNBC. When revenue rises but free cash flow drops that sharply, the market starts asking whether growth is becoming too expensive.

The third layer was legal risk. The child safety trial did not create concern from scratch. It escalated existing concern. Investors had already been dealing with a regulatory backdrop that included the FTC’s decision to appeal a previous antitrust ruling in January 2026, along with EU action tied to Meta’s WhatsApp for Business API policy and AI assistant access. The child safety case added a new legal front and made the risk feel more immediate.

The fourth layer was institutional positioning. When hedge funds or large shareholders reduce exposure, it can reinforce the idea that risk-reward is getting less attractive in the short term. That does not prove the bear case is right, but it can intensify downside momentum while uncertainty is high.

Why Today’s 4.4% Drop Is Different From the Prior Decline

Today’s 4.4% move appears different from the earlier multi-month slide because it looks more emotional than fundamental. The trial opening is a scheduled event, not a surprise earnings miss or a sudden collapse in ad demand. That distinction matters.

If a stock falls because revenue breaks down, margins collapse permanently, or user engagement weakens, investors usually need fresh operating improvement before buying the dip. Meta does not fit that pattern right now. Its core ad engine is still producing strong numbers. Q1 2026 revenue was $56.311 billion, and Q2 rose to $60.801 billion, putting first-half revenue at $117.111 billion, based on company filings and earnings materials.

What changed today was the legal headline intensity. Markets often compress risk into one trading day when a known event officially begins. That does not mean the business worsened overnight. It means investors applied a sharper discount to uncertainty. For dip buyers, that difference is important. An emotion-driven drop can reverse faster than a fundamentals-driven one, but only if no new damaging facts emerge.

What the Analyst Consensus of $767 Implies About Current Levels

A widely cited analyst consensus around $767 suggests notable upside from current levels around $550 to $560. Based on third-party market summaries, including Public and TradingView-sourced reporting, that implies roughly 35% to 38% upside.

That gap sends a useful message, but it should not be read too literally. It means many analysts still believe Meta stock is worth materially more than where it trades now because the ad business remains durable and AI investments could eventually support stronger monetization. It also suggests that at least some legal and spending risk is already reflected in valuation.

At the same time, target prices are not guarantees. They are models built on assumptions about revenue growth, margins, capital spending, and legal outcomes. If the trial produces an extreme operating risk, or if 2027 spending looks set to rise again at the same pace, those targets can come down quickly. So the consensus helps frame potential upside, but it does not remove uncertainty.

The Legal Risk That the 30% Decline Has Only Partially Priced

The biggest challenge in valuing Meta stock now is that legal risk does not behave like a normal earnings variable. You cannot plug it into a spreadsheet the way you model ad pricing or user growth. That is why the current 30% drawdown may have priced in some legal risk, but probably not all of it.

The market has already seen that Meta’s regulatory issues are not isolated. The FTC appeal kept antitrust pressure alive in 2026, and the European Commission’s interim measures around WhatsApp for Business API access showed that Meta’s control over distribution and AI access remains under close review. The child safety trial adds another front, and unlike routine compliance disputes, it carries reputational risk as well as possible business constraints.

This is also why comparisons to past large-industry legal fights matter. Markets often overreact at the start of a major trial because the narrative is easy to understand and emotionally charged. But final outcomes can take months or longer, and many headline-heavy cases end in settlements, negotiated remedies, or narrower-than-feared operating changes. That does not make the risk small. It just means the first wave of selling can be larger than the first wave of hard facts.

The Three Conditions That Make META a Buy at Current Levels

For investors considering Meta stock here, a disciplined buy case needs more than “it is down a lot.” Three conditions matter.

First, legal risk has to be mostly priced in already. In other words, current levels need to reflect the market’s expectation of a meaningful but manageable outcome. If the eventual result is financial pain without major disruption to Meta’s core advertising machine, then today’s discount may prove too deep.

Second, the Q3 revenue guide needs to hold. Meta told investors to expect Q3 2026 revenue between $61 billion and $64 billion. That makes the next earnings report a key checkpoint. If revenue lands inside or above that range, it would support the view that AI is helping recommendation quality and ad efficiency enough to keep the core engine growing.

Third, investors need some sign that capital spending is approaching a more digestible phase. The issue is not whether Meta should invest in AI. Most investors accept that it must. The issue is whether 2026 is a peak build year or just the start of an even steeper spending cycle into 2027. If management signals that the build-out begins to normalize, the valuation argument improves quickly.

Buy Condition	Why It Matters
Legal outcome stays within expected range	Supports the view that current levels already discount much of the trial risk
Q3 revenue confirms the $61B to $64B guide	Shows ad demand and AI-driven monetization are still offsetting spending pressure
CapEx growth begins to slow	Improves confidence that free cash flow can recover in 2027

The Three Reasons to Wait Before Buying

There is also a fair case for patience.

The first reason is simple: legal uncertainty can stay in the headlines for months. Even if the final outcome is less severe than feared, the path there may still keep pressure on sentiment. Stocks tied to open legal narratives often stay cheap longer than investors expect.

The second reason is that AI spending may not have peaked. Meta’s Q2 results already showed how aggressive the build-out is. If Q3 capital expenditures come in even higher, investors may worry that free cash flow compression is not temporary. That would likely keep a lid on any quick rerating.

The third reason is institutional behavior. When professional investors reduce exposure during a period of rising legal and spending risk, retail investors should at least pay attention. Institutions are not always right, but they often act early when the probability range widens.

The Investor Profile That Fits META at Current Levels

Meta stock at current levels is not for every investor. It fits best for people with at least a 12-month view, who are comfortable owning large-cap technology names through legal noise and who believe the ad business can remain strong while AI spending eventually becomes more productive.

It may also fit existing shareholders looking to average in carefully rather than make an all-at-once bet. That approach makes sense when a stock is caught between strong fundamentals and weak sentiment. In crypto terms, this is not very different from buying a quality blockchain ecosystem token during a heavy unlock-scare period: the underlying network may remain healthy, but valuation compresses because the market is uncertain about future supply, liquidity, or cash generation. With Meta, the pressure is not tokenomics or circulating supply. It is capital intensity, legal overhang, and the timing of return on investment.

On the other hand, shorter-term traders who need a clean three- to six-month setup may find better risk-reward elsewhere. If you react strongly to legal headlines or believe Meta’s AI spending resembles an open-ended balance sheet drain, waiting is the more rational choice.

FAQ

How much has META fallen from its 52-week high, and why?

Meta has fallen about 30% from its 52-week high of $790.80 to current levels around $550 to $560. The decline reflects a mix of heavier AI capital spending, weaker free cash flow, margin pressure, legal risk, and some institutional selling.

What makes today’s 4.4% drop different from the earlier decline?

Today’s move looks more like a sentiment-driven reaction to the child safety trial opening. The earlier decline built over months as investors reassessed Meta’s valuation due to spending and legal concerns.

What does the analyst consensus near $767 mean for Meta stock?

It suggests analysts still see meaningful upside from current levels and believe the core business is worth more than the market price. But that upside depends on legal outcomes and whether AI spending starts producing clearer returns.

What conditions would make buying META more convincing?

Three conditions matter most: legal risk being largely priced in, Q3 revenue landing within the company’s $61 billion to $64 billion guidance, and early signals that capital spending growth will slow after 2026.

What type of investor is best suited to buy META now?

The best fit is a long-term investor with a horizon of at least 12 months, some tolerance for legal and headline volatility, and confidence that Meta’s ad engine can keep funding future AI returns.

At this stage, Meta stock is not a simple bargain or a simple trap. It is a high-quality business moving through a period when valuation depends less on revenue strength and more on how much uncertainty investors are willing to carry. If you think the trial risk stays manageable and AI spending begins to earn its keep, current levels can make sense. If you want cleaner visibility, waiting for the next earnings checkpoint is the more disciplined move.